A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

被引:128
|
作者
Garfein, Richard S.
Golub, Elizabeth T.
Greenberg, Alan E.
Hagan, Holly
Hanson, Debra L.
Hudson, Sharon M.
Kapadia, Farzana
Latka, Mary H.
Ouellet, Lawrence.
Purcell, David W.
Strathdee, Steffanie A.
Thiede, Hanne
机构
[1] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Natl Res & Dev Inst, New York, NY USA
[4] Hlth Res Assoc, Los Angeles, CA USA
[5] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[6] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[7] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[8] Publ Hlth Seattle & King Cty, Seattle, WA USA
[9] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA
关键词
hepatitis C virus; HIV; injection drug use; peer education; randomized controlled trial; young adult;
D O I
10.1097/QAD.0b013e32823f9066
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). Design: We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. Results: The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.971, and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Conclusion: Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission. (C) 2007 Lippincott Williams & Wilkins.
引用
收藏
页码:1923 / 1932
页数:10
相关论文
共 50 条
  • [31] The future face of coinfection - Prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users
    Miller, CL
    Wood, E
    Spittal, PM
    Li, K
    Frankish, JC
    Braitstein, P
    Montaner, JSG
    Schechter, MT
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (02) : 743 - 749
  • [32] HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention
    Hagan, H
    Thiede, H
    Des Jarlais, DC
    AIDS, 2005, 19 : S199 - S207
  • [33] Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users
    Tsui, Judith I.
    Evans, Jennifer L.
    Lum, Paula J.
    Hahn, Judith A.
    Page, Kimberly
    JAMA INTERNAL MEDICINE, 2014, 174 (12) : 1974 - 1981
  • [34] The dynamics of injection drug users' personal networks and HIV risk behaviors
    Costenbader, Elizabeth C.
    Astone, Nan M.
    Latkin, Carl A.
    ADDICTION, 2006, 101 (07) : 1003 - 1013
  • [35] Alcohol and HIV sexual risk behaviors among injection drug users
    Arasteh, Karnyar
    Jarlais, Don C. Des
    Perlis, Theresa E.
    DRUG AND ALCOHOL DEPENDENCE, 2008, 95 (1-2) : 54 - 61
  • [36] HIV sexual risk behaviors among injection drug users in Shanghai
    Zhao, Min
    Du, Jiang
    Lu, Guang H.
    Wang, Qiu Y.
    Xu, Han
    Zhu, Min
    McCoy, Clyde B.
    DRUG AND ALCOHOL DEPENDENCE, 2006, 82 : S43 - S47
  • [37] Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
    Javadi, Abbasali
    Ataei, Behrooz
    Kassaian, Nazila
    Nokhodian, Zary
    Yaran, Majid
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 : S17 - S21
  • [38] Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal
    Kakchapati, Sampurna
    Maharjan, Manju
    Rawal, Bir Bahadhur
    Dixit, Sameer Mani
    ARCHIVES OF PUBLIC HEALTH, 2017, 75
  • [39] Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal
    Sampurna Kakchapati
    Manju Maharjan
    Bir Bahadhur Rawal
    Sameer Mani Dixit
    Archives of Public Health, 75
  • [40] HIV drug resistance and HIV transmission risk behaviors among active injection drug users
    Kozal, MJ
    Amico, KR
    Chiarella, J
    Cornman, D
    Fisher, W
    Fisher, J
    Friedland, G
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) : 106 - 109